[Protection of cells by nucleoside transport inhibitor combined with nebularine and the therapeutic effect on transplantable mouse tumors].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000008:administration & dosage; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003839:Deoxyadenosines / Q000008:administration & dosage / Q000031:analogs & derivatives; D004109:Dilazep / Q000008:administration & dosage; D005260:Female; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008815:Mice, Inbred Strains; D011684:Purine Nucleosides / Q000008:administration & dosage; D012263:Ribonucleosides / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D001593:Benzyl Compounds; D003839:Deoxyadenosines; D011684:Purine Nucleosides; D012263:Ribonucleosides; C005248:nebularine; D004109:Dilazep